Mechanism

CD86 + IL-10

Assets acting on this target.

Class
Bispecific anti-CD86/IL-10 fusion protein (ADAPTIR platform)
Research

Explore this mechanism at different depths

Research adds deeper and simplified explanation variants while preserving the same scientific register and source caveats.

Company

0 of 0 assets

No assets match these filters.

← all assets